Tuberculous meningitis other diagnostic studies: Difference between revisions
(Created page with "__NOTOC__ {{Tuberculous meningitis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== ...") |
m (Changes made per Mahshid's request) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Tuberculous meningitis}} | {{Tuberculous meningitis}} | ||
{{CMG}} | |||
==Other Diagnostic Studies== | |||
==== Nucleic acid amplification tests (NAAT) ==== | |||
This is a heterogeneous group of tests that use [[polymerase chain reaction]] (PCR) to detect mycobacterial nucleic acid. These test vary in which nucleic acid sequence they detect and vary in their accuracy. The two most common commercially available tests are the amplified mycobacterium tuberculosis direct test (MTD, Gen-Probe) and Amplicor. In 2007, a systematic review of NAAT by the NHS Health Technology Assessment Programme concluded that for diagnosing tuberculous meningitis "Individually, the AMTD test appears to perform the best (sensitivity 74% and specificity 98%) [page 87]" <REF NAME="pmid17266837">{{cite journal |author=Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, Drobniewski F, Lalvani A |title=A systematic review of rapid diagnostic tests for the detection of tuberculosis infection |journal=Health Technol Assess |volume=11 |issue=3 |pages=1-314 |year=2007 |id=PMID 17266837 | url = http://www.hta.nhsweb.nhs.uk/project/1247.asp}}</REF>. In the NHS [[meta-analysis]], they found the pooled prevalence of TB meningitis to be 29% [page 85]; however there was much heterogeneity in the reported sensitivities. Using a [http://medinformatics.uthscsa.edu/calculator/ clinical calculator], these numbers yield a [[positive predictive value]] of 94% and a [[negative predictive value]] of 90%; however the 30% prevalence may be high due to referral bias. Alternate estimates of disease prevalence can be entered into the [http://medinformatics.uthscsa.edu/calculator/ clinical calculator] to refine the predictive values. | |||
==References== | ==References== | ||
| Line 11: | Line 15: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Tuberculosis]] | [[Category:Tuberculosis]] | ||
[[Category:Needs | |||
[[Category:Needs overview]] | |||
Latest revision as of 19:03, 18 September 2017
|
Tuberculous meningitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tuberculous meningitis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Tuberculous meningitis other diagnostic studies |
|
Risk calculators and risk factors for Tuberculous meningitis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Other Diagnostic Studies
Nucleic acid amplification tests (NAAT)
This is a heterogeneous group of tests that use polymerase chain reaction (PCR) to detect mycobacterial nucleic acid. These test vary in which nucleic acid sequence they detect and vary in their accuracy. The two most common commercially available tests are the amplified mycobacterium tuberculosis direct test (MTD, Gen-Probe) and Amplicor. In 2007, a systematic review of NAAT by the NHS Health Technology Assessment Programme concluded that for diagnosing tuberculous meningitis "Individually, the AMTD test appears to perform the best (sensitivity 74% and specificity 98%) [page 87]" [1]. In the NHS meta-analysis, they found the pooled prevalence of TB meningitis to be 29% [page 85]; however there was much heterogeneity in the reported sensitivities. Using a clinical calculator, these numbers yield a positive predictive value of 94% and a negative predictive value of 90%; however the 30% prevalence may be high due to referral bias. Alternate estimates of disease prevalence can be entered into the clinical calculator to refine the predictive values.
References
- ↑ Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, Drobniewski F, Lalvani A (2007). "A systematic review of rapid diagnostic tests for the detection of tuberculosis infection". Health Technol Assess. 11 (3): 1–314. PMID 17266837.